Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Antioxid Redox Signal ; 34(11): 831-844, 2021 04 10.
Artículo en Inglés | MEDLINE | ID: mdl-32586104

RESUMEN

Significance: Persistent oxidative stress is a common feature of cancer cells, giving a specific weapon to selectively eliminate them. Ascorbate in pharmacological concentration can contribute to the suspended formation of hydroxyl radical via the Fenton reaction; thus, it can be an important element of the oxidative stress therapy against cancer cells. Recent Advances: The main components of ascorbate-induced cell death are DNA double-strand breaks via the production of hydroxyl radical and ATP depletion due to the activation of poly (ADP-ribose) polymerase 1. Presumably, DNA damage can be the primary contributor to the anticancer activity of pharmacological ascorbate, as opposed to the rupture of bioenergetics. The caspase independency of high-dose ascorbate-induced cell death proposed the possible involvement of several types of cell death, such as ferroptosis, necroptosis, and autophagy. Critical Issues: Ascorbate can target at least two key molecular features of cancer cells as a part of the anticancer therapy: the intrinsic or acquired resistance to cell death and the dysregulated metabolism of cancer cells. It seems probable that different concentrations of ascorbate alter the nature of induced cell death. Autophagy and necroptosis may play a role at intermediate concentrations, but caspase-independent apoptosis may dominate at higher concentrations. However, ascorbate behaves as an effective inhibitor of ferroptosis that may have crucial importance in its possible clinical application. Future Directions: The elucidation of the details and the links between high-dose ascorbate-induced cancer selective cell death mechanisms may give us a tool to form and apply synergistic cancer therapies. Antioxid. Redox Signal. 34, 831-844.


Asunto(s)
Ácido Ascórbico/uso terapéutico , Muerte Celular/efectos de los fármacos , Neoplasias/dietoterapia , Estrés Oxidativo/efectos de los fármacos , Apoptosis/efectos de los fármacos , Autofagia/efectos de los fármacos , Muerte Celular/genética , Roturas del ADN de Doble Cadena/efectos de los fármacos , Ferroptosis/efectos de los fármacos , Humanos , Necroptosis/efectos de los fármacos , Neoplasias/metabolismo , Neoplasias/patología , Poli(ADP-Ribosa) Polimerasa-1/genética , Especies Reactivas de Oxígeno/metabolismo
2.
Oxid Med Cell Longev ; 2019: 8156592, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30800210

RESUMEN

Ascorbate requiring Fe2+/2-oxoglutarate-dependent dioxygenases located in the nucleoplasm have been shown to participate in epigenetic regulation of gene expression via histone and DNA demethylation. Transport of dehydroascorbic acid is impaired in the endomembranes of fibroblasts from arterial tortuosity syndrome (ATS) patients, due to the mutation in the gene coding for glucose transporter GLUT10. We hypothesized that altered nuclear ascorbate concentration might be present in ATS fibroblasts, affecting dioxygenase activity and DNA demethylation. Therefore, our aim was to characterize the subcellular distribution of vitamin C, the global and site-specific changes in 5-methylcytosine and 5-hydroxymethylcytosine levels, and the effect of ascorbate supplementation in control and ATS fibroblast cultures. Diminished nuclear accumulation of ascorbate was found in ATS fibroblasts upon ascorbate or dehydroascorbic acid addition. Analyzing DNA samples of cultured fibroblasts from controls and ATS patients, a lower global 5-hydroxymethylcytosine level was found in ATS fibroblasts, which could not be significantly modified by ascorbate addition. Investigation of the (hydroxy)methylation status of specific regions in six candidate genes related to ascorbate metabolism and function showed that ascorbate addition could stimulate hydroxymethylation and active DNA demethylation at the PPAR-γ gene region in control fibroblasts only. The altered DNA hydroxymethylation patterns in patient cells both at the global level and at specific gene regions accompanied with decreased nuclear accumulation of ascorbate suggests the epigenetic role of vitamin C in the pathomechanism of ATS. The present findings represent the first example for the role of vitamin C transport in epigenetic regulation suggesting that ATS is a compartmentalization disease.


Asunto(s)
Arterias/anomalías , Ácido Ascórbico/metabolismo , Núcleo Celular/metabolismo , Metilación de ADN/genética , Fibroblastos/metabolismo , Fibroblastos/patología , Genoma Humano , Inestabilidad de la Articulación/genética , Enfermedades Cutáneas Genéticas/genética , Malformaciones Vasculares/genética , 5-Metilcitosina/análogos & derivados , 5-Metilcitosina/metabolismo , Células Cultivadas , Epigénesis Genética , Humanos , Modelos Biológicos , PPAR gamma/genética , PPAR gamma/metabolismo
3.
Oxid Med Cell Longev ; 2018: 6721530, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29636854

RESUMEN

The maintenance of cellular homeostasis is largely dependent on the ability of cells to give an adequate response to various internal and external stimuli. We have recently proposed that the life-and-death decision in endoplasmic reticulum (ER) stress response is defined by a crosstalk between autophagy, apoptosis, and mTOR-AMPK pathways, where the transient switch from autophagy-dependent survival to apoptotic cell death is controlled by GADD34. The aim of the present study was to investigate the role of epigallocatechin-3-gallate (EGCG), the major polyphenol of green tea, in promoting autophagy-dependent survival and to verify the key role in connecting GADD34 with mTOR-AMPK pathways upon prolonged ER stress. Our findings, obtained by using HEK293T cells, revealed that EGCG treatment is able to extend cell viability by inducing autophagy. We confirmed that EGCG-induced autophagy is mTOR-dependent and PKA-independent; furthermore, it also required ULK1. We show that pretreatment of cells with EGCG diminishes the negative effect of GADD34 inhibition (by guanabenz or siGADD34 treatment) on autophagy. EGCG was able to delay apoptotic cell death by upregulating autophagy-dependent survival even in the absence of GADD34. Our data suggest a novel role for EGCG in promoting cell survival via shifting the balance of mTOR-AMPK pathways in ER stress.


Asunto(s)
Catequina/análogos & derivados , Estrés del Retículo Endoplásmico/fisiología , Serina-Treonina Quinasas TOR/metabolismo , Té/química , Autofagia/efectos de los fármacos , Catequina/farmacología , Catequina/uso terapéutico , Supervivencia Celular , Humanos
4.
Int J Biochem Cell Biol ; 42(1): 157-66, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19819344

RESUMEN

Maintenance of the reduced state of luminal pyridine nucleotides in the endoplasmic reticulum - an important pro-survival factor in the cell - is ensured by the concerted action of glucose-6-phosphate transporter and hexose-6-phosphate dehydrogenase. The mechanism by which the redox imbalance leads to cell death was investigated in HepG2 cells. The chemical inhibition of the glucose-6-phosphate transporter, the silencing of hexose-6-phosphate dehydrogenase and/or the glucose-6-phosphate transporter, or the oxidation of luminal NADPH by themselves did not cause a significant loss of cell viability. However, these treatments caused ER calcium store depletion. If these treatments were supplemented with the administration of a subliminal dose of the oxidizing agent menadione, endoplasmic reticulum vacuolization and a loss of viability were observed. Combined treatments resulted in the activation of ATF6 and procaspase-4, and in the induction of Grp78 and CHOP. In spite of the presence of UPR markers and proapoptotic signaling the effector caspases - caspase-3 and caspase-7 - were not active. On the other hand, an elevation of the autophagy marker LC3B was observed. Immunohistochemistry revealed a punctuated distribution of LC3B II, coinciding with the vacuolization of the endoplasmic reticulum. The results suggest that altered redox state of endoplasmic reticulum luminal pyridine nucleotides sensitizes the cell to autophagy.


Asunto(s)
Autofagia , Retículo Endoplásmico/patología , Nucleótidos/metabolismo , Estrés Oxidativo , Piridinas/metabolismo , Antiportadores/metabolismo , Autofagia/efectos de los fármacos , Biomarcadores/metabolismo , Calcio/metabolismo , Deshidrogenasas de Carbohidratos/metabolismo , Caspasas Iniciadoras/metabolismo , Retículo Endoplásmico/efectos de los fármacos , Chaperón BiP del Retículo Endoplásmico , Activación Enzimática/efectos de los fármacos , Silenciador del Gen , Células Hep G2 , Humanos , Proteínas Asociadas a Microtúbulos/metabolismo , Proteínas de Transporte de Monosacáridos/metabolismo , NADP/deficiencia , Oxidación-Reducción/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Compuestos de Sulfhidrilo/metabolismo , Vitamina K 3/farmacología
5.
FEBS Lett ; 581(8): 1693-8, 2007 Apr 17.
Artículo en Inglés | MEDLINE | ID: mdl-17412326

RESUMEN

Effect of 5-100 microM epigallocatechin gallate (EGCG) on hepatic glucose 6-phosphatase (G6Pase) system was investigated. EGCG inhibited G6Pase in intact but not in permeabilized rat liver microsomes, suggesting the interference with the transport. However, EGCG did not hinder microsomal glucose 6-phosphate (G6P) uptake. Instead, it increased the accumulation of radioactivity after the addition of [(14)C]G6P, presumably due to a slower release of [(14)C]glucose, the product of luminal hydrolysis. Indeed, EGCG was found to inhibit microsomal glucose efflux. Since G6Pase activity is depressed by glucose in a concentration-dependent manner, we concluded that EGCG inhibits G6Pase through an elevated luminal glucose level.


Asunto(s)
Catequina/análogos & derivados , Flavonoles/farmacología , Glucosa-6-Fosfatasa/antagonistas & inhibidores , Hígado/enzimología , Té/química , Animales , Catequina/aislamiento & purificación , Catequina/farmacología , Flavonoles/aislamiento & purificación , Glucosa/farmacología , Glucosa-6-Fosfatasa/análisis , Glucosa-6-Fosfato/metabolismo , Hígado/efectos de los fármacos , Hígado/ultraestructura , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/enzimología , Ratas
6.
Int J Biochem Cell Biol ; 39(5): 922-30, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17317271

RESUMEN

Toxic endogenous or exogenous compounds can be inactivated by various conjugation reactions. Glucuronidation (i.e. conjugation with glucuronate) is especially important due to the large number of drugs and chemical carcinogens that are detoxified through this pathway. Stable and harmless glucuronides can be reactivated by enzymatic hydrolysis thus inhibitors of glucuronidase activity reduce the risk of chemical carcinogenesis. The aim of this study was to reveal whether this mechanism contributes to the anti-cancer effect of green tea flavanols, which has been shown in various animal models. Therefore, we investigated the effect of these polyphenols on deglucuronidation in rat liver microsomes and in Hepa 1c1c7 mouse hepatoma cells, using 4-methylumbelliferyl glucuronide as model substrate. Tea flavanols inhibited beta-glucuronidase in intact vesicles, where glucuronide transport across the microsomal membrane is rate-limiting, but were almost ineffective in permeabilized vesicles. Epigallocatechin gallate, the major green tea flavanol was shown to have a concentration-dependent inhibitory effect on both beta-glucuronidase activity and glucuronide transport in native vesicles. Epigallocatechin gallate also inhibited beta-glucuronidase activity in native Hepa 1c1c7 mouse hepatoma cells, while failed to affect the enzyme in alamethicin-permeabilized cells, where the endoplasmic membrane barrier was eliminated. Our findings indicate that tea flavanols inhibit deglucuronidation in the endoplasmic reticulum at the glucuronide transport stage. This phenomenon might potentially contribute to the cancer-preventing dietary or pharmacological effect attributed to these catechins.


Asunto(s)
Catequina/análogos & derivados , Retículo Endoplásmico/metabolismo , Flavonoides/farmacología , Glucurónidos/metabolismo , Fenoles/farmacología , Té/química , Animales , Anticarcinógenos/farmacología , Transporte Biológico/efectos de los fármacos , Catequina/química , Catequina/farmacología , Línea Celular Tumoral , Cromatografía Líquida de Alta Presión , Relación Dosis-Respuesta a Droga , Retículo Endoplásmico/efectos de los fármacos , Activación Enzimática/efectos de los fármacos , Glucuronidasa/metabolismo , Masculino , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/metabolismo , Estructura Molecular , Polifenoles , Ratas , Ratas Wistar
7.
Biochem Pharmacol ; 72(5): 640-6, 2006 Aug 28.
Artículo en Inglés | MEDLINE | ID: mdl-16806089

RESUMEN

Green tea is getting into the focus of scientific interest due to its beneficial health effects, most of which are attributed to its catechin content. Polyphenolic tea catechins have antioxidant, antiproliferative, antiangiogenic and proapoptotic effects, which makes them promising anticancer compounds. Other poly-hydroxy molecules have similar antitumor potentials through the inhibition of glucosidase II, which affects the glycoprotein maturation and quality control in the endoplasmic reticulum. We investigated the effect of tea catechins on glucosidase II activity in rat liver microsomes using 4-methylumbelliferyl glucoside and 4-nitrophenyl glucoside as substrates. A concentration-dependent inhibition with non-competitive kinetics was found. The IC50 and Ki values for certain tea catechins were comparable with those of N-butyldeoxynojirimycin, the widely used glucosidase inhibitor. The possible interference of tea catechins with the glycoprotein processing in the endoplasmic reticulum should be considered as a potential mechanism of their dietary or pharmacological effects.


Asunto(s)
Flavonoles/farmacología , Inhibidores de Glicósido Hidrolasas , Té/química , Animales , Catequina/análogos & derivados , Catequina/farmacología , Cromatografía Líquida de Alta Presión , Cinética , Masculino , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/enzimología , Ratas , Ratas Wistar , alfa-Glucosidasas
8.
J Nutr ; 135(11): 2530-4, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16251606

RESUMEN

Insufficient ascorbate intake causes scurvy in certain species. Beyond its known functions, it has been suggested that ascorbate participates in oxidative protein folding in the endoplasmic reticulum (ER). Because redox imbalance in this organelle might cause ER stress and apoptosis, we hypothesized that this might contribute to the pathology of scurvy. Guinea pigs were divided into 7 groups: the control group was fed a commercial guinea pig food containing 0.1 g/100 g ascorbate for 4 wk, 5 groups consumed an ascorbate-free food for 0, 1, 2, 3, or 4 wk and 1 group was fed this scorbutic diet for 2 wk and then the commercial food plus 1 g/L ascorbate in drinking water for 2 wk. TBARS generation and the expression of some ER chaperones and foldases were determined in hepatic microsomes. The apoptotic index was assessed in histological sections. Although ascorbate, measured by HPLC, was undetectable in the livers of the guinea pigs after they had consumed the scorbutic diet for 2 wk, the microsomal TBARS level was elevated relative to the initial value only at wk 4. Western blot revealed the induction of GRP78, GRP94, and protein disulfide isomerase at wk 3 and 4. Apoptosis was greater than in the control, beginning at wk 3. None of the alterations occurred in the groups fed the commercial guinea pig food or ascorbate-free food followed by ascorbate supplementation. Therefore, persistent ascorbate deficiency leads to ER stress, unfolded protein response, and apoptosis in the liver, suggesting that insufficient protein processing participates in the pathology of scurvy.


Asunto(s)
Apoptosis , Retículo Endoplásmico/patología , Hígado/patología , Escorbuto/patología , Animales , Ácido Ascórbico/análisis , Western Blotting , Peso Corporal , Retículo Endoplásmico/fisiología , Chaperón BiP del Retículo Endoplásmico , Cobayas , Proteínas de Choque Térmico/análisis , Hígado/química , Masculino , Glicoproteínas de Membrana/análisis , Microsomas Hepáticos/química , Chaperonas Moleculares/análisis , Tamaño de los Órganos , Proteínas/análisis , Sustancias Reactivas al Ácido Tiobarbitúrico/análisis
9.
Orv Hetil ; 146(31): 1621-4, 2005 Jul 31.
Artículo en Húngaro | MEDLINE | ID: mdl-16158610

RESUMEN

Lycopene is a carotenoid found predominantly in tomatoes and tomato products. In contrast to beta-carotene it is not a precursor of vitamin A in humans. Lycopene is not destroyed during food processing, moreover its bioavailability improves. Lycopene is the most powerful antioxidant amongst carotenoids. Beside the antioxidant effect it influences the expression of various proteins (enzymes of biotransformation, cyclin D1, connexins). According to epidemiologic studies tomato lycopene may reduce the risk of prostate cancer and cardiovascular diseases. Positive effects are also hypothesized in case of other diseases such as osteoporosis, neurodegenerative diseases and hypertension. Neither adverse effects upon lycopene supplementation nor lycopene toxicity have been reported. Therefore, several arguments support the consumption of natural lycopene, whilst there are no contraindications according to the present knowledge.


Asunto(s)
Antioxidantes , Carotenoides , Animales , Anticarcinógenos/química , Anticarcinógenos/farmacología , Antioxidantes/química , Antioxidantes/farmacología , Disponibilidad Biológica , Carotenoides/química , Carotenoides/farmacología , Enfermedad Coronaria/prevención & control , Eritema/etiología , Eritema/prevención & control , Manipulación de Alimentos , Humanos , Licopeno , Piel/efectos de los fármacos , Piel/efectos de la radiación , Rayos Ultravioleta/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA